SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-050758
Filing Date
2021-08-11
Accepted
2021-08-11 09:14:29
Documents
2
Period of Report
2021-08-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4079
2 POA DOCUMENT poa.txt EX-24.4_1003169 3101
  Complete submission text file 0001209191-21-050758.txt   8593
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Levy Howard (Reporting) CIK: 0001672333 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51173 | Film No.: 211162184